Navigation Links
Novel therapy may prove effective in treatment of 30 percent of cancers
Date:5/13/2009

A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer (IRIC) of the Universit de Montral, has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients. Published in the journal Blood (First Edition), the study demonstrates that ribavirin suppresses the activities of the eIF4E gene in patients. This gene is dysregulated in 30 percent of cancers including breast, prostate, head and neck, colon and stomach cancer.

The study, inspired by the exciting discoveries made by Dr. Borden at IRIC, was a joint project between her research group, who monitored molecular events in trial patients, and Dr. Sarit Assouline of the Segal Cancer Centre, Jewish General Hospital, who led the clinical part of the trial.

The integration of these two teams made it possible to rapidly move from a research lab to patient tests. The study team targeted the gene by giving trial participants a mimic of its natural target, ribavirin. "Our results are the first to show that targeting eIF4E in humans is clinically beneficial," explains Dr. Borden. "We also found that ribavirin not only blocks eIF4E, it has no side effect on patients."

The trial studied patients with M4/M5 acute myeloid leukemia who had undergone several other treatments that had previously failed. "We had striking clinical improvements with even partial and complete remissions," indicated Assouline.

Dr. Wilson Miller, director of the Clinical Research Unit, Jewish General Hospital, and co-investigator in the trial added: "It's rare that discoveries in basic research move to clinical so quickly and successfully."

The next challenge for this team is to overcome the resistance that develops over time to ribavirin. "Combination therapy with chemotherapeutic agents may enhance the efficacy of this treatment," explains Borden, "Trials in the near future are planned to overcome
'/>"/>

Contact: Carolyne Lord
carolyne.lord@umontreal.ca
514-343-7282
University of Montreal
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Telesso Technologies wins Popular Science Invention Award for its novel peripheral IV catheter
2. Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference
3. Ironwood and Forest to Present Additional Phase 2b Data for Novel Gastrointestinal Agent Linaclotide
4. Novel gene predicts local recurrence in early onset breast cancer
5. Novel gene predicts local recurrence in early-onset breast cancer
6. Positive Results for Ophthotechs Novel Therapy for Wet AMD - Study of Anti-PDGF and Anti-VEGF Therapy Shows Significant Neovascular Regression and Enhanced Visual Outcome
7. Fixed Dosed Combination Agents and Novel Antihypertensives Are Expected to Face Tougher Formulary Restrictions
8. Compendia Bioscience Announces Collaboration with MDS Pharma Services to Deliver Novel Solution for Oncology Drug Development
9. Spiritual Leaders Teachings Collected in New Novel
10. Novel role of protein in generating amyloid-beta peptide
11. Novel cancer drug reduces neuroblastoma growth by 75 percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2014)... (PRWEB) July 26, 2014 The number ... state and federal litigations since the 2012 recall of ... 3,700 filings, Bernstein Liebhard LLP reports. According to a ... 2,064 cases have been filed in the New Jersey’s ... Stem and the ABG II Modular Hip Stem Litigation, ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 As reported ... trends are changing based on 3 factors: smaller spaces, ... several top bathroom trend of 2014 lists, including ... increased popularity. Amerec , a leading manufacturer of ... steam bathing largely due to smaller spaces and an ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 ... recently updated by Vkool.com, this is a ... safe methods for treating all types of ...     Tinnitus due to Ménière's ... ,     Nerve pathway tinnitus , ...
(Date:7/26/2014)... TX (PRWEB) July 26, 2014 ... or encephalomyelitis disseminata, is an inflammatory disease in ... the brain and spinal cord are damaged. This ... nervous system to communicate, resulting in a wide ... and sometimes psychiatric problems. Multiple sclerosis takes several ...
(Date:7/26/2014)... July 26, 2014 Another DePuy Pinnacle hip ... Inc., has been filed by Wright & Schulte LLC. ... on behalf of an Erie County, Ohio man who alleges ... hip and groin since receiving his Pinnacle Hip implant in ... will be forced to undergo a complex and risky revision ...
Breaking Medicine News(10 mins):Health News:Stryker Hip Lawsuit Filings in State and Federal Litigations Continue to Rise, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit Filings in State and Federal Litigations Continue to Rise, Bernstein Liebhard LLP Reports 3Health News:Amerec Finds Bathroom Design Trends Change Based on Water Consumption and Other Factors 2Health News:Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 5
... , , BEDFORD, Ohio, July ... announced FDA approval to begin shipping Ceftriaxone for Injection USP. ... Roche. Ceftriaxone is a semisynthetic, broad-spectrum antibiotic used to treat ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20070809/CLTH157LOGO ...
... can greatly influence rotavirus, spread, CDC says , THURSDAY, ... infection, a major cause of infant illness in the ... understanding of when and where infections are likely to ... new research suggests. , A team including scientists from ...
... OAKLAND, Calif., July 16 Arcadian Health announced today that Robert ... the BMO Capital Markets sponsored 9th Annual Focus on Healthcare Conference ... Broadway Hotel. Arcadian is a leading provider of Medicare Advantage health ... and other provider groups. , , ...
... , The hospital is the highest-rated ... , , CHICAGO, July 16 Northwestern ... it the highest ranked in Illinois -- as part of U.S. News & ... authoritative and influential guide evaluated 4,861 medical centers nationwide and 174 were chosen ...
... July 16 The Lewin Group today released ... claims pose in Medicaid managed care. The authors of the report recommend ... used in the Medicare Advantage managed care program. , ... Out-of-Network Payment Stu d y, " was commissioned by ...
... , , , ... AZN ) announced today that it will provide free medication ... under one of the company,s prescription savings programs. , ... for healthcare facilities provides medicines free of charge to community ...
Cached Medicine News:Health News:Bedford Laboratories(TM) to Begin Shipping Ceftriaxone for Injection USP 2Health News:New Insights Could Help Shield Babies From Diarrhea Bug 2Health News:Arcadian Chairman and Chief Executive Officer, Robert Fahlman, to Present at Focus on Healthcare Conference in New York City 2Health News:Northwestern Memorial Among America's Best Hospitals in 11 Clinical Specialties According to U.S. News' 2009 Rankings 2Health News:Northwestern Memorial Among America's Best Hospitals in 11 Clinical Specialties According to U.S. News' 2009 Rankings 3Health News:New Lewin Report Shows Need for National Medicaid Out-of-Network Claims Policy 2Health News:AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured 2Health News:AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured 3
(Date:7/25/2014)... N.C. , July 25, 2014  In today,s ... is costly and challenging - as is managing a ... Is it possible - or even preferable ... If so, where can you combine resources and activities, ... These are just a few of ...
(Date:7/25/2014)... 2014 /PRNewswire-iReach/ -- ScriptPro, of Mission, ... Powers Lake, Wisconsin , announce that they ... co-marketing agreement allowing ScriptPro to bring TCGRx adherence ... the United States . ScriptPro is a ... systems to retail and ambulatory pharmacies. TCGRx distributes ...
(Date:7/25/2014)... Trinidad and Tobago , July 25, 2014 ... the Trinidad & Tobago Ministry of Health approved ... therapy that significantly increases the cure rate from ... infected with the genotype 1 virus. Telaprevir is ... the trade brand INCIVO®. Photo - ...
Breaking Medicine Technology:Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3
... Systech International, innovator of Packaging Execution Systems ... leading supplier of end-of-line packaging systems, today announced ... global serialization requirements at Pack Expo 2010 in ... opportunity to examine first hand the actual system ...
... Oct. 27 Alan L. Rubino, former Hoffmann-La Roche ... companies, and Timothy G. Rothwell, former Chairman, CEO, and ... American Therapeutics, Inc.   Mr. Rubino will ... function as the company,s Chairman.  The company,s key emphasis ...
Cached Medicine Technology:Systech and Pester Pac Automation Exhibit Integrated Serialization Solution at Pack Expo 2010 2Veteran Pharmaceutical Executives Form New American Therapeutics, Inc. 2
... Blind Performance Specimens are intended for ... handling and transportation guidelines, including chain ... Testing Programs regulated by the Substance ... (SAMHSA), Health and Human Services Department ...
... Reticulocyte Stain is an aqueous ... use in manual methods of ... has a one year shelf ... and can be used in ...
Seroconversion and Antigen Panel Chart...
... Amplichek CT/GC Controls are ... the precision of test procedures ... Neisseria gonorrhoeae. Since they are ... used with either urine or ...
Medicine Products: